Data / Form D filings / Regulus Therapeutics Inc.
Regulus Therapeutics Inc.: Form D filings
Regulus Therapeutics Inc., a pharmaceuticals company in San Diego, CA, filed 9 Form D notices with the SEC between 2010 and 2021. The latest, on December 6, 2021, reports $34.6 million sold of a $34.6 million offering to 16 investors.
Find out what Regulus Therapeutics Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4224 CAMPUS POINT COURT, SUITE 210, San Diego, CA, 92121
- Phone
- (858) 202-6300
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1505512
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 6, 2021 | New notice | $34,624,999 | $34,624,999 | $0 | 16 | Nov 30, 2021 | sec.gov |
| Dec 17, 2020 | New notice | $34,537,555 | $19,383,037 | $15,154,518 | 18 | Dec 4, 2020 | sec.gov |
| May 14, 2019 | New notice | $79,343,959 | $16,736,889 | $62,607,070 | 21 | May 7, 2019 | sec.gov |
| Feb 6, 2014 | New notice | $9,999,992 | $9,999,992 | $0 | 1 | Feb 4, 2014 | sec.gov |
| Oct 23, 2012 | New notice | $5,000,000 | $5,000,000 | $0 | 1 | Aug 15, 2012 | sec.gov |
| Oct 23, 2012 | New notice | $25,000,000 | $25,000,000 | $0 | 1 | Oct 10, 2012 | sec.gov |
| Nov 15, 2010 | New notice | $9,999,996 | $9,999,996 | $0 | 1 | Oct 27, 2010 | sec.gov |
| Nov 15, 2010 | New notice | $20,000,000 | $20,000,000 | $0 | 2 | Mar 3, 2009 | sec.gov |
| Nov 15, 2010 | New notice | $29,800,000 | $29,800,000 | $0 | 2 | Jan 2, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph Hagan | Executive Officer, Director | |
| Christopher Aker | Executive Officer | |
| Alice S. Huang | Director | |
| Cris Calsada | Executive Officer | |
| Jake R. Nunn | Director | |
| David Baltimore | Director | |
| Denis Drygin | Executive Officer | |
| William H. Rastetter | Director | |
| Pascale H. Witz | Director | |
| Kathryn J. Collier | Director | |
| Stelios Papadopoulos | Director | |
| Simos H. Simeonidis | Director | |
| Hugh H. Rosen | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Dec 6, 2021 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Regulus Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.